↑ Rising
Business
Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused
Novartis and Bristol Myers have paused CAR-T trials after patient deaths, raising safety concerns in the biopharma industry.
Clinical Trials
33 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Clinical Trials
This hub groups 33 separate news trends connected to Clinical Trials, spanning June 19, 2026 through September 1, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 276 article observations and 258 source signals, led by Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test
BioNTech and Roche have halted a mid-stage cancer vaccine trial after more deaths occurred in the treatment group than in the control group.
◼ Archived
Health
🔮 fades ✓
SINGLE-AF: DOAC Therapy vs. No Anticoagulation in AFib Patients at Intermediate Risk For Stroke
A major clinical trial has yielded surprising results about the use of anticoagulants in atrial fibrillation patients.
◼ Archived
Business
🔮 fades ✓
In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs
AstraZeneca and Ionis' failed heart disease trial raises questions about the future of RNA drugs
▲ Peaking
Health
🔮 fades
Cell therapy substantially reduces severe rheumatoid arthritis in first clinical trial
First CAR‑T trial signals remission for severe rheumatoid arthritis, sparking hope for an immune reset.
◼ Archived
Health
🔮 fades ✓
Arthritis drug may help regrow up to 80% of hair in alopecia areata
A drug used to treat arthritis is showing promise in treating alopecia areata, a condition that causes hair loss.
◼ Archived
Business
🔮 fades ✓
Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanism
Roche’s $2.5 billion pact for Hanmi’s muscle‑sparing obesity drug ignites expectations for a new weight‑loss breakthrough
▲ Peaking
Health
🔮 fades ✓
Unexpected GLP-1 side effect? Studies show the meds may help people with addictions
Studies suggest GLP-1 medications may have unexpected benefits for people with addictions.
◼ Archived
Health
🔮 fades ✓
You want to join a clinical trial. Here’s what to know about the hurdles.
Patients eager to join clinical trials face numerous barriers, from financial to logistical.
◼ Archived
Business
🔮 fades ✓
Moderna, Merck breakthrough could usher in wave of cancer vaccines
A cancer vaccine breakthrough is stirring debate over profits and public health, as Moderna and Merck's stock prices surge.
◼ Archived
Health
🔮 fades ✓
Could GLP-1s help with alcohol use disorder? A Philly VA doctor is leading a national trial to find out.
A national trial is exploring whether GLP-1s, known for weight loss, can also help with alcohol use disorder.
◼ Archived
Health
🔮 fades ✓
A pill that mimics exercise? Early results on drug designed to maintain both weight loss and muscle mass
A drug designed to mimic exercise has passed its first human test, sparking interest in the medical community.
◼ Archived
Business
Exclusive: Third death in China's popular but opaque trials revealed, this time in CAR-T
A third death in China's gene therapy trials raises questions about the safety and oversight of these experimental treatments.
◼ Archived
Business
🔮 fades ✓
The Surprising Reason This Biotech Plummeted 69%
EyePoint Pharmaceuticals' stock plummets after a clinical trial setback, leaving investors reeling and analysts divided.
◼ Archived
Business
🔮 fades ✓
AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review
AstraZeneca has abruptly terminated its Phase 3 trial for the lung cancer drug volrustomig, halting development after an internal review.
◼ Archived
Health
🔮 fades ✓
First Human Trial of Poop Transplant to Treat Food Allergies Shows Promising Results
A single human trial of fecal microbiota transplantation has shown promise in treating peanut allergies.
◼ Archived
Health
🔮 fades ✓
Stopping statins in people over 75 at low risk for heart disease didn’t increase deaths
A new study suggests that stopping statins in low-risk seniors may not increase mortality, but experts debate the findings.
◼ Archived
Business
🔮 fades ✓
AI brings savings to clinical trials: study
Research indicates AI integration could deliver 82 times the return on investment in oncology clinical trials while reshaping the drug development market.
◼ Archived
Business
🔮 fades ✓
Regeneron backs $75M series A for antibody upstart Infinimmune
Alameda-based biotech Infinimmune has secured $75 million in Series A funding to advance its antibody pipeline for atopic dermatitis and inflammatory diseases.
◼ Archived
Health
🔮 fades ✓
Could one blood test detect multiple cancers earlier? UNC researchers hope to find out
A single blood test could revolutionize cancer detection by identifying multiple cancers earlier.
◼ Archived
Business
🔮 fades ✓
Silence Therapeutics aims at Takeda with new data in rare blood cancer
Silence Therapeutics' new data on a rare blood cancer drug could disrupt Takeda's market position.
◼ Archived
Health
🔮 fades ✓
Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’
Patients in Illinois and Utah are among the first to receive a new experimental drug for pancreatic cancer.
◼ Archived
Health
🔮 fades ✓
Dronabinol for nightmares in post-traumatic stress disorder: a randomized controlled trial
A randomized controlled trial published in Nature indicates that the synthetic cannabinoid Dronabinol effectively reduces trauma-related nightmares in PTSD patients.
◼ Archived
Health
🔮 fades ✓
Magic mushrooms can ease depression resistant to other treatments, major study finds
A major randomized clinical trial indicates that psilocybin, the active compound in magic mushrooms, provides relief for treatment-resistant depression.
◼ Archived
Health
🔮 fades ✓
Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak
Moderna's Phase 1 Ebola vaccine trial begins as the outbreak in DR Congo continues to spread
◼ Archived
Health
🔮 holds ✗
First person gets new experimental vaccine for Ebola
Human clinical trials have begun for the world's first vaccine targeting the Bundibugyo ebolavirus outbreak.
◼ Archived
Health
🔮 fades ✗
Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients
A first-in-human trial for a mutant KRAS vaccine shows promise in preventing pancreatic cancer among high-risk patients.
◼ Archived
Health
🔮 fades ✓
New weight loss pill that’s beating oral Ozempic
A new oral GLP-1 weight-loss pill is showing results that outperform oral Ozempic in major clinical trials.
◼ Archived
Health
🔮 fades ✓
There's no treatment designed for the Ebola strain ravaging DRC. But now there's hope
New clinical trials and expanded medical facilities offer hope for a viral Ebola strain in the Democratic Republic of Congo that lacks a specific treatment.
◼ Archived
Health
🔮 fades ✓
Grand Rapids oncologist says experimental pancreatic cancer drug showing promise in trials offers hope
An experimental drug for pancreatic cancer is generating hope among medical professionals and patients.
◼ Archived
Health
🔮 fades ✓
US provides Ebola treatment for outbreak in Congo, bringing trials closer
The US is providing experimental Ebola treatments for an outbreak in Congo, accelerating clinical trials.
◼ Archived
Business
🔮 fades ✓
FDA to launch pilot program to speed up early-stage clinical trials
The FDA is launching a pilot program to accelerate early-stage clinical trials to enhance U.S. competitiveness in drug research.
◼ Archived
Health
🔮 fades ✓
The omega-3 supplement you take may not be helping your brain
Recent studies question the effectiveness of omega-3 supplements for brain health.